April 21, 2017 - By Pete Kolinski
They currently have a GBX 9.00 target price per share on Reneuron Group (LON:RENE). N 1 Singer’s target would suggest a potential upside of 309.09% from the company’s last stock close price. This was shown in a research note on 21 April.
SEAFARER EXPLORATION (OTCMKTS:SFRX) had an increase of 1830.71% in short interest. SFRX’s SI was 270,300 shares in April as released by FINRA. Its up 1830.71% from 14,000 shares previously. It is 0.00% or $0 reaching $0.0032 per share. It is down 39.13% since September 22, 2016 and is uptrending. It has outperformed by 28.31% the S&P500.
About 6.54 million shares traded or 207.04% up from the average. ReNeuron Group Plc (LON:RENE) has declined 20.00% since September 21, 2016 and is downtrending. It has underperformed by 30.82% the S&P500.
ReNeuron Group plc is a clinical-stage company. The company has market cap of 73.31 million GBP. The Company, through its subsidiaries, is engaged in researching and developing cell therapies. It currently has negative earnings. The Company’s products are allogeneic.
Among 2 analysts covering ReNeuron Group PLC (LON:RENE), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ReNeuron Group PLC has GBX 15 highest and GBX 9 lowest target. GBX 12’s average target is 424.02% above currents GBX 2.29 stock price. ReNeuron Group PLC had 7 analyst reports since September 15, 2015 according to SRatingsIntel. The firm has “Buy” rating by N+1 Singer given on Monday, January 9. N+1 Singer maintained ReNeuron Group Plc (LON:RENE) on Wednesday, January 4 with “Buy” rating. The stock of ReNeuron Group Plc (LON:RENE) has “Buy” rating given on Monday, December 7 by N+1 Singer. The stock of ReNeuron Group Plc (LON:RENE) earned “Buy” rating by N+1 Singer on Tuesday, September 15. The firm earned “Buy” rating on Monday, December 5 by N+1 Singer. On Monday, January 4 the stock rating was maintained by N+1 Singer with “Buy”. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, April 4.
Seafarer Exploration Corp. , formerly Organetix, Inc., is a development-stage company. The company has market cap of $7.96 million. The Firm operates as an underwater salvage and exploration company. It currently has negative earnings. The principal business of the Company is to engage in the archaeologically-sensitive exploration, documentation, and recovery of historic shipwrecks with the objective of exploring and discovering Colonial-era shipwrecks.
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.